FDA Ruling on Statin Therapy

Published Online: Wednesday, December 19, 2012
Follow Pharmacy_Times:
In this video, David Dichek, MD, of the University of Washington Medical Center, discusses an FDA warning regarding the potential for cognitive problems and elevated blood sugar associated with taking statins. He also discusses how to address concerns that patients may have about taking statins in light of the waning.

Related Articles
Even though smoking can exacerbate respiratory conditions and limit the efficacy of their treatment, patients often purchase cigarettes while filling prescriptions for asthma or antihypertensive drugs at pharmacies.
Patients with moderate-to-severe psoriasis are more likely to have uncontrolled hypertension.
The FDA today approved the first drug-coated balloon for reopening arteries in the thigh and knee that are narrowed or blocked due to peripheral artery disease.
Latest Issues
$auto_registration$